Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
August 24 2023 - 4:10PM
Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global
clinical-stage biopharmaceutical company dedicated to discovering
and developing innovative and highly efficacious cell therapies for
the treatment of cancer, today announced that the management team
will participate in and attend one-on-one meetings at two upcoming
investor conferences.
Wells Fargo Healthcare Conference
Fireside Chat: September 6th at 1:30pm ETOne-on-one meetings:
September 6, 2023Location: Boston
Citi’s 18th Annual
BioPharma ConferencePanel Presentation - Cell Therapies in
Autoimmune: September 7th at 1:50 pm ETOne-on-one & group
meetings: September 7, 2023Location: Boston
A webcast of the presentations will be available
on the News and Events section of Gracell’s investor website. A
replay of the webcast will be available for 30 days following the
event.
About Gracell
Gracell Biotechnologies Inc. (“Gracell”) is a
global clinical-stage biopharmaceutical company dedicated to
discovering and developing breakthrough cell therapies for the
treatment of cancers and autoimmune diseases. Leveraging its
innovative FasTCAR and TruUCAR technology platforms and SMART CAR™
technology module, Gracell is developing a rich clinical-stage
pipeline of multiple autologous and allogeneic product candidates
with the potential to overcome major industry challenges that
persist with conventional CAR-T therapies, including lengthy
manufacturing time, suboptimal cell quality, high therapy cost, and
lack of effective CAR-T therapies for solid tumors and autoimmune
diseases. The lead candidate BCMA/CD19 dual-targeting FasTCAR-T
GC012F is currently being evaluated in the clinical studies for the
treatment of multiple myeloma, B-NHL and systemic lupus
erythematosus (SLE). For more information on Gracell, please visit
www.gracellbio.com. Follow @GracellBio on LinkedIn.
Media contact
Marvin Tang
marvin.tang@gracellbio.com
Investor contact
Gracie Tong
gracie.tong@gracellbio.com
Gracell Biotechnologies (NASDAQ:GRCL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gracell Biotechnologies (NASDAQ:GRCL)
Historical Stock Chart
From Sep 2023 to Sep 2024